Fleifel D, Cook J
Cancers (Basel). 2023; 15(18).
PMID: 37760529
PMC: 10526231.
DOI: 10.3390/cancers15184559.
Islam R, Jenkins C, Cao Q, Wong J, Bilenky M, Carles A
iScience. 2023; 26(6):106795.
PMID: 37213235
PMC: 10199266.
DOI: 10.1016/j.isci.2023.106795.
Kim Y, Lee B, Kim D, Um S, Cho E, Han J
J Clin Med. 2020; 9(6).
PMID: 32498288
PMC: 7356912.
DOI: 10.3390/jcm9061694.
Ito Y, Bae S, Chuang L
Nat Rev Cancer. 2015; 15(2):81-95.
PMID: 25592647
DOI: 10.1038/nrc3877.
Logan T, Villapol S, Symes A
PLoS One. 2013; 8(3):e59250.
PMID: 23555640
PMC: 3605457.
DOI: 10.1371/journal.pone.0059250.
Tyrosyl phosphorylation toggles a Runx1 switch.
Neel B, Speck N
Genes Dev. 2012; 26(14):1520-6.
PMID: 22802526
PMC: 3404380.
DOI: 10.1101/gad.198051.112.
Runx1 deletion or dominant inhibition reduces Cebpa transcription via conserved promoter and distal enhancer sites to favor monopoiesis over granulopoiesis.
Guo H, Ma O, Speck N, Friedman A
Blood. 2012; 119(19):4408-18.
PMID: 22451420
PMC: 3362359.
DOI: 10.1182/blood-2011-12-397091.
Runx1 loss minimally impacts long-term hematopoietic stem cells.
Cai X, Gaudet J, Mangan J, Chen M, De Obaldia M, Oo Z
PLoS One. 2011; 6(12):e28430.
PMID: 22145044
PMC: 3228772.
DOI: 10.1371/journal.pone.0028430.
Phosphorylation of RUNX1 by cyclin-dependent kinase reduces direct interaction with HDAC1 and HDAC3.
Guo H, Friedman A
J Biol Chem. 2010; 286(1):208-15.
PMID: 21059642
PMC: 3012976.
DOI: 10.1074/jbc.M110.149013.
The human SWI/SNF complex associates with RUNX1 to control transcription of hematopoietic target genes.
Bakshi R, Hassan M, Pratap J, Lian J, Montecino M, van Wijnen A
J Cell Physiol. 2010; 225(2):569-76.
PMID: 20506188
PMC: 3045090.
DOI: 10.1002/jcp.22240.
ETV6/RUNX1 abrogates mitotic checkpoint function and targets its key player MAD2L1.
Krapf G, Kaindl U, Kilbey A, Fuka G, Inthal A, Joas R
Oncogene. 2010; 29(22):3307-12.
PMID: 20190817
PMC: 4194424.
DOI: 10.1038/onc.2010.53.
A new gene selection procedure based on the covariance distance.
Hu R, Qiu X, Glazko G
Bioinformatics. 2009; 26(3):348-54.
PMID: 19996162
PMC: 2815661.
DOI: 10.1093/bioinformatics/btp672.
'Runxs and regulations' of sensory and motor neuron subtype differentiation: implications for hematopoietic development.
Stifani S, Ma Q
Blood Cells Mol Dis. 2009; 43(1):20-6.
PMID: 19349198
PMC: 2700053.
DOI: 10.1016/j.bcmd.2009.03.001.
Cell cycle and developmental control of hematopoiesis by Runx1.
Friedman A
J Cell Physiol. 2009; 219(3):520-4.
PMID: 19235904
PMC: 4741264.
DOI: 10.1002/jcp.21738.
The leukemogenic t(8;21) fusion protein AML1-ETO controls rRNA genes and associates with nucleolar-organizing regions at mitotic chromosomes.
Bakshi R, Zaidi S, Pande S, Hassan M, Young D, Montecino M
J Cell Sci. 2008; 121(Pt 23):3981-90.
PMID: 19001502
PMC: 2904240.
DOI: 10.1242/jcs.033431.
Deletion of Mtg16, a target of t(16;21), alters hematopoietic progenitor cell proliferation and lineage allocation.
Chyla B, Moreno-Miralles I, Steapleton M, Ann Thompson M, Bhaskara S, Engel M
Mol Cell Biol. 2008; 28(20):6234-47.
PMID: 18710942
PMC: 2577421.
DOI: 10.1128/MCB.00404-08.
Integrative analysis of RUNX1 downstream pathways and target genes.
Michaud J, Simpson K, Escher R, Buchet-Poyau K, Beissbarth T, Carmichael C
BMC Genomics. 2008; 9:363.
PMID: 18671852
PMC: 2529319.
DOI: 10.1186/1471-2164-9-363.
Deletion of histone deacetylase 3 reveals critical roles in S phase progression and DNA damage control.
Bhaskara S, Chyla B, Amann J, Knutson S, Cortez D, Sun Z
Mol Cell. 2008; 30(1):61-72.
PMID: 18406327
PMC: 2373760.
DOI: 10.1016/j.molcel.2008.02.030.
Genome-wide analysis of the homeobox C6 transcriptional network in prostate cancer.
McCabe C, Spyropoulos D, Martin D, Moreno C
Cancer Res. 2008; 68(6):1988-96.
PMID: 18339881
PMC: 2584783.
DOI: 10.1158/0008-5472.CAN-07-5843.
Loss of TLE1 and TLE4 from the del(9q) commonly deleted region in AML cooperates with AML1-ETO to affect myeloid cell proliferation and survival.
Dayyani F, Wang J, Yeh J, Ahn E, Tobey E, Zhang D
Blood. 2008; 111(8):4338-47.
PMID: 18258796
PMC: 2288729.
DOI: 10.1182/blood-2007-07-103291.